Aclaris Therapeutics, Inc.

ACRS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001557746

SEC filings (opens in a new tab)

No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Aclaris Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of ACRS: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	133	3	110	−20
Shares	56.0M	267.5K	59.3M	+3.52M (+6.3%)
Value	$814.9M	$3.89M	$1.02B	+$210.9M (+26.0%)

3 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to ACRS in Q1 2022
Institution	Shares	Value	% of portfolio
Ra Capital Management, L.P.	1,817,808	$31.3M	0.68%
Assenagon Asset Management S.A.	507,435	$8.75M	0.03%
Frazier Life Sciences Management, L.P.	408,329	$7.04M	0.60%
Amalgamated Bank	8,306	$143.0K	0.00%
Amalgamated Financial Corp.	8,306	$143.0K	0.00%
Parallel Advisors, LLC	600	$11.0K	0.00%
High Net Worth Advisory Group LLC	500	$9.00K	0.00%
Lindbrook Capital, LLC	208	$4.00K	0.00%
Massmutual Trust Co FSB	55	$1.00K	0.00%
Quadrant Capital Group LLC	84	$1.00K	0.00%

Sold out (30)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of ACRS in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Cormorant Asset Management, LP	900,000	$13.1M
Frazier Management LLC	408,329	$5.94M
Darwin Global Management, Ltd.	216,143	$3.14M
Hamilton Lane Advisors LLC	97,550	$1.42M
Tri Locum Partners LP	55,433	$806.0K
Pura Vida Investments, LLC	48,266	$702.0K
Franklin Resources Inc	41,994	$611.0K
Jump Financial, LLC	32,000	$465.0K
Jane Street Group, LLC	31,228	$454.0K
Sender Co & Partners, Inc.	30,132	$438.0K
Engineers Gate Manager LP	27,453	$399.0K
Martingale Asset Management L P	23,702	$345.0K
D. E. Shaw & Co., Inc.	22,864	$332.0K
Victory Capital Management Inc	22,650	$329.0K
Alpine Global Management, LLC	20,528	$298.0K
Fox Run Management, L.L.C.	19,368	$282.0K
Old Mission Capital LLC	15,663	$228.0K
Trexquant Investment LP	14,587	$212.0K
Dynamic Technology Lab Private Ltd	13,873	$201.0K
SG Americas Securities, LLC	13,679	$199.0K
Two Sigma Advisers, LP	13,300	$193.0K
Nomura Holdings Inc	13,068	$190.0K
Two Sigma Investments, LP	13,044	$190.0K
Blair William & Co	12,800	$186.0K
Cherry Creek Investment Advisors, Inc.	11,440	$166.0K
Boulder Hill Capital Management LP	11,200	$163.0K
Walleye Capital LLC	10,341	$150.0K
Point72 Hong Kong Ltd	1,784	$26.0K
TCI Wealth Advisors, Inc.	309	$4.00K
Truvestments Capital LLC	150	$2.00K

Not filed for Q1 2022 yet (3)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ACRS in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Asymmetry Capital Management, L.P.	198,493	$2.89M
AlphaCentric Advisors LLC	68,000	$989.0K
Harbour Investments, Inc.	1,000	$15.0K